[PDF][PDF] Isolation and Identification of Antifungal Metabolites from Juncus torreyi
SH Park, JW Kang, GH Park, SJ Jo, KW Min… - Natural Product …, 2024 - e-nps.or.kr
Plants belonging to the genus Juncus are widely distributed across North America, which
are known to make a diverse array of bioactive natural products. In 2022, Juncus torreyi, a …
are known to make a diverse array of bioactive natural products. In 2022, Juncus torreyi, a …
[PDF][PDF] Lack of TYK2 Signaling Enhances Host Resistance to Candida albicans Skin Infection
B Strobl, S Miranda, C Lassnig, K Schmidhofer… - 2024 - researchgate.net
13 Candida albicans is the most common human fungal pathogen, causing diseases
ranging from 14 local to life-threating systemic infections. Tyrosine kinase 2 (TYK2), a crucial …
ranging from 14 local to life-threating systemic infections. Tyrosine kinase 2 (TYK2), a crucial …
Association between Genotype of IL17A rs (22759130 G/A) and IL17F rs (763780 T/C) Polymorphism in the Type 2 Diabetes Mellitus Patients with Oral Fungal …
AS Kadhim - Biomolecular and Health Science Journal, 2023 - journals.lww.com
Methods: This is a case− control study which consisted of 150 subjects (75 patients and 75
controls). Tetra-primer amplification refractory mutation system-polymerase chain reaction …
controls). Tetra-primer amplification refractory mutation system-polymerase chain reaction …
Insuflación rectal con ozono en infecciones intestinales
V Borroto Rodríguez, M Bueno Cortés - Revista Cubana de Medicina, 2023 - scielo.sld.cu
Warning: XSLTProcessor:: transformToXml ()[xsltprocessor. transformtoxml]: I/O warning:
failed to load external entity" file:////srv-new/scielo/www/bases/xml/med/v62n4/1561-302X …
failed to load external entity" file:////srv-new/scielo/www/bases/xml/med/v62n4/1561-302X …
[PDF][PDF] Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage. Microorganisms 2023, 11 …
Y Rebai, L Wagner, M Gnaien, ML Hammer, M Kapitan… - 2023 - researchgate.net
Candida albicans is a pathobiont of the gastrointestinal tract. It can contribute to the diversity
of the gut microbiome without causing harmful effects. When the immune system is …
of the gut microbiome without causing harmful effects. When the immune system is …
[PDF][PDF] Insuflación rectal con ozono en infecciones intestinales
MB Cortà - Revista Cubana de Medicina, 2023 - revmedicina.sld.cu
Introducción: Las infecciones intestinales se relacionan con trastornos del sistema inmune y
de la microbiota intestinal. Pueden ser recurrentes y producir otras alteraciones intestinales …
de la microbiota intestinal. Pueden ser recurrentes y producir otras alteraciones intestinales …
35 Immunodiagnostics
D Liu - Handbook of Molecular Biotechnology, 2024 - books.google.com
Based on the ability of an antibody to specifically recognize and bind an antigen,
immunodiagnostics (also referred to as immunodiagnostic assays, immunological assays …
immunodiagnostics (also referred to as immunodiagnostic assays, immunological assays …
ارزیابی حساسیت ضدقارچی مشتقات 3 پیرول بر روي ایزوله هاي بالینی کاندید-4-دي-هیدروپیریمیدین-ا-H ال-1-(H2).
خسرو قشعري, سعید مهدوي عمران… - … of Medical Sciences …, 2022 - search.ebscohost.com
Background and purpose: There is an increasing rate of drug resistance to azole among
Candida species, so, finding new compounds that are effective in laboratory conditions …
Candida species, so, finding new compounds that are effective in laboratory conditions …
Investigating the Effectiveness of Spirocyclopropane-Oxindole Derivatives on Clinical Isolates of Candida albicans
P Rafati, J Jafarzade, A Hoseinnejad… - Hormozgan Medical …, 2024 - hmj.hums.ac.ir
Objectives: Given the spread of azole resistance in Candida albicans (C. albicans),
searching for new potent compounds, such as spirocyclopropane-oxindole derivatives is …
searching for new potent compounds, such as spirocyclopropane-oxindole derivatives is …
[引用][C] Research Paper Investigating the Effectiveness of Spirocyclopropane-Oxindole Derivatives on Clinical Isolates of Candida albicans
P Rafati, J Jafarzade, A Hoseinnejad, A Khalilpour…